Lantheus Holdings (LNTH)

$96.23 +2.16 (2.30%)
Market Cap 6.12B
Revenue (ttm) 1.54B
Net Income (ttm) 233.56M
EPS (ttm) N/A
PE Ratio 18.69
Forward PE 21.86
Profit Margin 15.15%
Debt to Equity Ratio 0.47
Volume 1,230,200
Avg Vol 967,458
Day's Range N/A - N/A
Shares Out 65.11M
Stochastic %K 100%
Beta -0.08
Analysts Strong Sell
Price Target $103.00

Company Profile

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area wi...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 978 671 8001
Fax: 978 671 8860
Address:
201 Burlington Road, South Building, Bedford, United States
Synaptric
Synaptric May. 13 at 1:31 PM
15 good-looking healthcare charts in this sad, narrow, semi/tech-only market. $XLV $CNC $GKOS $LNTH $JAZZ
0 · Reply
RadioIsotope25
RadioIsotope25 May. 10 at 6:57 PM
$RADX $NVS $CATX $LNTH Huge Radiopharmaceutical Conference
3 · Reply
stockydennis
stockydennis May. 8 at 4:01 PM
$LNTH wow
0 · Reply
__LucidDreamer__
__LucidDreamer__ May. 8 at 3:47 PM
$LNTH $RADX Lantheus doing great this week. Radx…not so much. Not chasing LNTH though…will let it run a while. Did nibble on radx as it neared $4.
0 · Reply
ZacksSCR
ZacksSCR May. 8 at 1:36 PM
$LNTH: Lantheus Reports 1Q:26 Financial and Operational Results https://buff.ly/kWX1aWl
0 · Reply
Jcolay
Jcolay May. 7 at 2:45 PM
$LNTH nice beat
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 11:42 AM
$LNTH Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.83 up 72.64% YoY • Reported revenue of $377.33M up 1.23% YoY • Lantheus reaffirmed its full year 2026 corporate guidance, expecting revenue between $1.4B and $1.45B, and adjusted fully diluted earnings per share to be in the range of $5.00 to $5.25.
0 · Reply
__LucidDreamer__
__LucidDreamer__ May. 6 at 8:46 PM
$LNTH started small position as basket w $RADX If ER drop, may just avg in lower. We find out soon!
0 · Reply
Avocado_smash
Avocado_smash May. 4 at 10:34 PM
$LNTH Structure and Trend strength up>
0 · Reply
PaulVoice
PaulVoice May. 4 at 7:48 PM
$LNTH screaming: buy me😁
0 · Reply
Latest News on LNTH
Lantheus price target raised to $115 from $98 at Truist

2026-05-11T19:44:38.000Z - 1 day ago

Lantheus price target raised to $115 from $98 at Truist

Lantheus price target raised to $100 from $95 at Mizuho

2026-05-08T13:19:29.000Z - 5 days ago

Lantheus price target raised to $100 from $95 at Mizuho

Lantheus price target raised to $115 from $85 at Citizens

2026-05-08T10:00:53.000Z - 5 days ago

Lantheus price target raised to $115 from $85 at Citizens

Lantheus price target raised to $94 from $82 at Goldman Sachs

2026-05-07T23:08:10.000Z - 5 days ago

Lantheus price target raised to $94 from $82 at Goldman Sachs

Lantheus Holdings Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 6 days ago

Lantheus Holdings Earnings Call Transcript: Q1 2026

Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update

May 7, 2026, 7:00 AM EDT - 6 days ago

Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update

Lantheus price target raised to $97 from $84 at B. Riley

2026-05-01T13:49:23.000Z - 12 days ago

Lantheus price target raised to $97 from $84 at B. Riley

Lantheus price target raised to $98 from $89 at Truist

2026-04-15T12:38:30.000Z - 4 weeks ago

Lantheus price target raised to $98 from $89 at Truist

Lantheus price target raised to $95 from $85 at Mizuho

2026-04-13T14:46:36.000Z - 4 weeks ago

Lantheus price target raised to $95 from $85 at Mizuho

Lantheus announces three-month extension of LNTH-2501 PDUFA date

2026-03-17T20:22:00.000Z - 2 months ago

Lantheus announces three-month extension of LNTH-2501 PDUFA date

Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

Mar 17, 2026, 4:01 PM EDT - 2 months ago

Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

Lantheus price target raised to $110 from $105 at Jefferies

2026-03-17T19:25:19.000Z - 2 months ago

Lantheus price target raised to $110 from $105 at Jefferies

Lantheus Holdings Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 8:00 AM EDT - 2 months ago

Lantheus Holdings Transcript: Leerink Global Healthcare Conference 2026

Lantheus announces FDA approval of Pylarify TruVu injection

2026-03-06T21:05:15.000Z - 2 months ago

Lantheus announces FDA approval of Pylarify TruVu injection

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection

Mar 6, 2026, 4:01 PM EST - 2 months ago

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection

Lantheus Holdings Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 11:10 AM EST - 2 months ago

Lantheus Holdings Transcript: TD Cowen 46th Annual Health Care Conference

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

Mar 2, 2026, 12:19 PM EST - 2 months ago

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

Lantheus receives U.S. FDA tentative approval for Lutetium Lu 177

2026-03-02T13:51:41.000Z - 2 months ago

Lantheus receives U.S. FDA tentative approval for Lutetium Lu 177

Lantheus price target raised to $89 from $82 at Truist

2026-03-02T12:33:17.000Z - 2 months ago

Lantheus price target raised to $89 from $82 at Truist

Lantheus price target raised to $89 from $82 at Truist

2026-03-02T12:29:38.000Z - 2 months ago

Lantheus price target raised to $89 from $82 at Truist

Lantheus price target raised to $85 from $72 at Mizuho

2026-02-27T12:48:01.000Z - 2 months ago

Lantheus price target raised to $85 from $72 at Mizuho

Lantheus price target raised to $85 from $78 at Citizens

2026-02-27T10:55:33.000Z - 2 months ago

Lantheus price target raised to $85 from $78 at Citizens

Lantheus downgraded to Hold from Buy at JonesResearch

2026-02-26T21:37:11.000Z - 2 months ago

Lantheus downgraded to Hold from Buy at JonesResearch

Lantheus price target raised to $85 from $75 at TD Cowen

2026-02-26T18:45:59.000Z - 2 months ago

Lantheus price target raised to $85 from $75 at TD Cowen

Lantheus upgraded to Outperform from Market Perform at William Blair

2026-02-26T16:56:10.000Z - 2 months ago

Lantheus upgraded to Outperform from Market Perform at William Blair

Lantheus Holdings Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:00 AM EST - 2 months ago

Lantheus Holdings Earnings Call Transcript: Q4 2025

Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 26, 2026, 7:00 AM EST - 2 months ago

Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

Feb 12, 2026, 8:00 AM EST - 3 months ago

Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies

Jan 2, 2026, 8:00 AM EST - 4 months ago

Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)

Dec 7, 2025, 11:21 AM EST - 5 months ago

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)

Lantheus Holdings Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 6 months ago

Lantheus Holdings Earnings Call Transcript: Q3 2025

Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 6, 2025, 7:02 AM EST - 6 months ago

Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update

LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH) DEADLINE ALERT Bernstein Liebhard LLP Reminds Lantheus Holdings, Inc. Investors of Upcoming Deadline

Oct 27, 2025, 10:08 AM EDT - 7 months ago

LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH) DEADLINE ALERT Bernstein Liebhard LLP Reminds Lantheus Holdings, Inc. Investors of Upcoming Deadline

Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time

Oct 23, 2025, 8:30 AM EDT - 7 months ago

Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

Sep 24, 2025, 1:00 AM EDT - 8 months ago

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

Sep 22, 2025, 5:29 AM EDT - 8 months ago

Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

Did you lose money in LNTH? Shareholders Who Incurred Significant Losses in Lantheus Holdings, Inc. Should Contact Robbins LLP for Information

Sep 19, 2025, 6:33 PM EDT - 8 months ago

Did you lose money in LNTH? Shareholders Who Incurred Significant Losses in Lantheus Holdings, Inc. Should Contact Robbins LLP for Information

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lantheus Holdings, Inc. (LNTH)

Sep 10, 2025, 8:00 PM EDT - 8 months ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lantheus Holdings, Inc. (LNTH)

Lantheus Holdings Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 7:00 AM EDT - 8 months ago

Lantheus Holdings Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Lantheus Holdings Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 10 months ago

Lantheus Holdings Earnings Call Transcript: Q2 2025

Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent

Aug 6, 2025, 6:45 AM EDT - 10 months ago

Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent

Synaptric
Synaptric May. 13 at 1:31 PM
15 good-looking healthcare charts in this sad, narrow, semi/tech-only market. $XLV $CNC $GKOS $LNTH $JAZZ
0 · Reply
RadioIsotope25
RadioIsotope25 May. 10 at 6:57 PM
$RADX $NVS $CATX $LNTH Huge Radiopharmaceutical Conference
3 · Reply
stockydennis
stockydennis May. 8 at 4:01 PM
$LNTH wow
0 · Reply
__LucidDreamer__
__LucidDreamer__ May. 8 at 3:47 PM
$LNTH $RADX Lantheus doing great this week. Radx…not so much. Not chasing LNTH though…will let it run a while. Did nibble on radx as it neared $4.
0 · Reply
ZacksSCR
ZacksSCR May. 8 at 1:36 PM
$LNTH: Lantheus Reports 1Q:26 Financial and Operational Results https://buff.ly/kWX1aWl
0 · Reply
Jcolay
Jcolay May. 7 at 2:45 PM
$LNTH nice beat
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 11:42 AM
$LNTH Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $1.83 up 72.64% YoY • Reported revenue of $377.33M up 1.23% YoY • Lantheus reaffirmed its full year 2026 corporate guidance, expecting revenue between $1.4B and $1.45B, and adjusted fully diluted earnings per share to be in the range of $5.00 to $5.25.
0 · Reply
__LucidDreamer__
__LucidDreamer__ May. 6 at 8:46 PM
$LNTH started small position as basket w $RADX If ER drop, may just avg in lower. We find out soon!
0 · Reply
Avocado_smash
Avocado_smash May. 4 at 10:34 PM
$LNTH Structure and Trend strength up>
0 · Reply
PaulVoice
PaulVoice May. 4 at 7:48 PM
$LNTH screaming: buy me😁
0 · Reply
SuperGreenToday
SuperGreenToday May. 2 at 12:19 AM
$LNTH Share Price: $85.51 Contract Selected: Oct 16, 2026 $85 Calls Buy Zone: $10.88 – $13.44 Target Zone: $20.12 – $24.59 Potential Upside: 75% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
STACKD0E
STACKD0E May. 2 at 12:02 AM
$LNTH $RLAY 🙃✨️
0 · Reply
Dirtyari
Dirtyari Apr. 30 at 9:49 PM
$LNTH push above 85,3 and let the party start
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 30 at 3:59 PM
$RADX Asymmetrical upside right from CEO’s slide. Gotta be in it to win it. $CATX $LNTH $PSTV $AKTS
0 · Reply
StockConsultant
StockConsultant Apr. 27 at 1:29 PM
$LNTH Lantheus stock, watch for a top of range breakout at https://stockconsultant.com/?LNTH
0 · Reply
BioTechHealthX
BioTechHealthX Apr. 26 at 6:22 PM
$LNTH AI in healthcare isn’t just a concept for Lantheus—it’s a business. Learn how its diagnostic imaging solutions are already driving revenue growth while positioning the company for long-term expansion. https://biotechhealthx.com/biotech-news/is-it-a-wise-move-to-acquire-lantheus-holdings-lnth-shares-today/
0 · Reply
GlobalMarketBulletin
GlobalMarketBulletin Apr. 26 at 6:02 PM
$LNTH AI in healthcare isn’t just a concept for Lantheus—it’s a business. Learn how its diagnostic imaging solutions are already driving revenue growth while positioning the company for long-term expansion. https://biotechhealthx.com/biotech-news/is-it-a-wise-move-to-acquire-lantheus-holdings-lnth-shares-today/
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 25 at 5:35 PM
$RADX $5 million cash earned coming in July non-dilutive from Australia. They may be signaling openness to strategic interest Not raising right now also keeps the cap table cleaner if: Lantheus Holdings or Novartis start circling post-data. If they raised aggressively today: it could weaken a buyout narrative or signal they expect to go it alone $LNTH $NVS
2 · Reply
Peligroso
Peligroso Apr. 24 at 3:05 PM
$RADX IMO $GEHC will be the ultimate buyer. They recognize the growth potential of PET and are building out their pharmaceutical diagnostics segment. $LNTH is obv another potential buyer but they are a bit low on cash after multiple radiopharma acquisitions last year.
2 · Reply
RadioIsotope25
RadioIsotope25 Apr. 24 at 1:52 PM
$RADX Probability-adjusted valuation 🔵 RADX RAD101: → 65% × $700M = $455M Therapeutics (combined optionality discounted): → ~10% × $700M = $70M 👉 Total expected value ≈ $525M $CATX $LNTH $PSTV $TLX
0 · Reply
BioTechHealthX
BioTechHealthX Apr. 23 at 12:04 AM
$BFLY $LNTH $RXRX $SDGR $SLP Discover the top 10 best medical AI stocks to buy now as artificial intelligence transforms healthcare, drug discovery, and diagnostics. These high-growth AI healthcare stocks could deliver massive upside potential in 2026 and beyond. https://biotechhealthx.com/biotech-news/top-10-best-medical-ai-stocks-that-could-deliver-100-returns/
0 · Reply
RadioIsotope25
RadioIsotope25 Apr. 21 at 2:36 PM
$AKTS is on fire and $RADX has just as good or better radiopharmaceuticals and much deeper pipeline and backed by a premier radiopharma company Lantheus $LNTH
0 · Reply